Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuntaro Ikegawa

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Frontiers in Immunology|September 16, 2021
Harnessing Treg Homeostasis to Optimize Posttransplant Immunity: Current Concepts and Future PerspectivesShuntaro Ikegawa, Ken-Ichi Matsuoka
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 17, 2013
[Discussion meeting on the daily practice of leukemia]Masahiro Kizaki, Tetsuhiko Nomura, Shuntaro Ikegawa, et al.
International Journal of Hematology|October 7, 2018
Cytomegalovirus meningitis in a patient with relapsed acute myeloid leukemiaKaito Harada, Noritaka Sekiya, Shuntaro Ikegawa, et al.
Blood Advances|December 11, 2019
PTCy ameliorates GVHD by restoring regulatory and effector T-cell homeostasis in recipients with PD-1 blockadeShuntaro Ikegawa, Yusuke Meguri, Takumi Kondo, et al.
Pathology Oncology Research : POR|April 4, 2015
Impact of prior azacitidine on the outcome of allogeneic hematopoietic transplantation for myelodysplastic syndromeGaku Oshikawa, Kousuke Yoshioka, Yukie Takahashi, et al.
NMC Case Report Journal|October 14, 2022
A Case of Relapsed Primary Central Nervous System Lymphoma Treated with CD19-directed Chimeric Antigen Receptor T Cell TherapyRyo Mizuta, Yoshihiro Otani, Kentaro Fujii, et al.
Internal Medicine (Tokyo, Japan)|June 30, 2024
Activated CD4<sup>+</sup> T Cell Proportion in the Peripheral Blood Correlates with the Duration of Cytokine Release Syndrome and Predicts Clinical Outcome after Chimeric Antigen Receptor T Cell TherapyWataru Kitamura, Noboru Asada, Shuntaro Ikegawa, et al.
Immunohorizons|June 11, 2021
Pretransplant Short-Term Exposure of Donor Graft Cells to ITK Selective Inhibitor Ameliorates Acute Graft-versus-Host Disease by Inhibiting Effector T Cell Differentiation while Sparing Regulatory T CellsTakumi Kondo, Shuntaro Ikegawa, Takuya Fukumi, et al.
Transplantation and Cellular Therapy|June 27, 2026
The association between hyponatremia and immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T cell therapyKenta Hayashino, Nobuharu Fujii, Wataru Kitamura, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 16, 2022
Successful neutrophil engraftment supported by granulocyte transfusion in adult allogeneic transplant patients with peri-transplant active infectionShuntaro Ikegawa, Nobuharu Fujii, Keiko Fujii, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|September 16, 2021
Harnessing Treg Homeostasis to Optimize Posttransplant Immunity: Current Concepts and Future PerspectivesShuntaro Ikegawa, Ken-Ichi Matsuoka
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 17, 2013
[Discussion meeting on the daily practice of leukemia]Masahiro Kizaki, Tetsuhiko Nomura, Shuntaro Ikegawa, et al.
International Journal of Hematology|October 7, 2018
Cytomegalovirus meningitis in a patient with relapsed acute myeloid leukemiaKaito Harada, Noritaka Sekiya, Shuntaro Ikegawa, et al.
Blood Advances|December 11, 2019
PTCy ameliorates GVHD by restoring regulatory and effector T-cell homeostasis in recipients with PD-1 blockadeShuntaro Ikegawa, Yusuke Meguri, Takumi Kondo, et al.
Pathology Oncology Research : POR|April 4, 2015
Impact of prior azacitidine on the outcome of allogeneic hematopoietic transplantation for myelodysplastic syndromeGaku Oshikawa, Kousuke Yoshioka, Yukie Takahashi, et al.
NMC Case Report Journal|October 14, 2022
A Case of Relapsed Primary Central Nervous System Lymphoma Treated with CD19-directed Chimeric Antigen Receptor T Cell TherapyRyo Mizuta, Yoshihiro Otani, Kentaro Fujii, et al.
Internal Medicine (Tokyo, Japan)|June 30, 2024
Activated CD4<sup>+</sup> T Cell Proportion in the Peripheral Blood Correlates with the Duration of Cytokine Release Syndrome and Predicts Clinical Outcome after Chimeric Antigen Receptor T Cell TherapyWataru Kitamura, Noboru Asada, Shuntaro Ikegawa, et al.
Immunohorizons|June 11, 2021
Pretransplant Short-Term Exposure of Donor Graft Cells to ITK Selective Inhibitor Ameliorates Acute Graft-versus-Host Disease by Inhibiting Effector T Cell Differentiation while Sparing Regulatory T CellsTakumi Kondo, Shuntaro Ikegawa, Takuya Fukumi, et al.
Transplantation and Cellular Therapy|June 27, 2026
The association between hyponatremia and immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T cell therapyKenta Hayashino, Nobuharu Fujii, Wataru Kitamura, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 16, 2022
Successful neutrophil engraftment supported by granulocyte transfusion in adult allogeneic transplant patients with peri-transplant active infectionShuntaro Ikegawa, Nobuharu Fujii, Keiko Fujii, et al.
Pageof 5